Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2026-03-01 @ 12:20 AM
Study NCT ID:
NCT04822805
Status:
UNKNOWN
Last Update Posted:
2021-03-30
First Post:
2021-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
Sponsor:
First People's Hospital of Hangzhou
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent High-grade Glioma | View |
Keywords: